| Financial Year |
March 31 2023 |
| Monetary Funds |
3,215,249,302.38 |
| Held-for-trading Financial Assets |
14,883,350.00 |
| Notes Receivable |
2,358,698.05 |
| Accounts Receivable |
1,523,913,536.17 |
| Advances to Suppliers |
369,323,974.55 |
| Other Receivables |
127,624,902.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,607,899.68 |
| Inventories |
15,986,929,055.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
822,435,203.67 |
| Total Current Assets |
23,246,292,966.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
51,964,568.13 |
| Investment Properties |
642,646,096.21 |
| Fixed Assetes |
550,285,887.50 |
| Under-construction Projects |
4,044,422.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
129,018,230.68 |
| R&D expenses |
3,579,594.39 |
| Goodwill |
4,940,424.17 |
| Long-Term Deferred and Prepaid Expenses |
16,412,747.29 |
| Deferred Income Tax Assets |
164,219,313.94 |
| Other Non-Current Assets |
45,477,213.43 |
| Sub-Total of Non-Current Assets |
1,635,423,719.76 |
| Total Assets |
24,881,716,685.76 |
| Short-Term Loans |
2,743,664,276.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
260,655,530.66 |
| Accounts Payable |
2,068,275,223.43 |
| Accounts Received In Advance |
20,929,983.83 |
| Employee Compensation Payable |
75,926,683.51 |
| Taxes Payable |
1,393,330,852.21 |
| Interest Payable |
-- |
| Dividend Payable |
1,113,235.90 |
| Other payables |
545,019,700.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,816,867,711.65 |
| Other Current Liabilities |
424,798,588.60 |
| Sub-Total of Current Liabilities |
14,430,085,079.28 |
| Long-term Loans |
4,545,032,090.63 |
| Bonds Payable |
489,518,535.17 |
| Long-Term Accounts Payable |
12,275.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
30,827,840.35 |
| Deferred Income Tax Liabilities |
3,836,719.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,069,739,236.95 |
| Total Liabilities |
19,499,824,316.23 |
| Paid-In Capital(Or Share Stock) |
1,570,754,217.00 |
| Capital Surplus |
2,085,132,322.93 |
| Surplus Reserve |
340,470,132.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,186,277,928.47 |
| Minority Stockholder's Interest |
398,151,802.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,983,740,567.41 |
| Owner's Equity（Stockholder's Equity） |
5,381,892,369.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,881,716,685.76 |
